Xarelto® (rivaroxaban) is an anticoagulant or blood thinner medication used as a treatment for reducing the risk of stroke and blood clots, particularly among patients with atrial fibrillation or following hip or knee replacement surgery. Marketed by Bayer Healthcare and developed by Janssen Pharmaceuticals, Xarelto was approved by The Food & Drug Administration (FDA) in 2011 to treat patients who have pulmonary embolism, deep vein thrombosis, atrial fibrillation not caused by heart valve problems.
While Xarelto has become a top-selling medication in recent years, there have been a number of adverse reports associated with the drug, the most concerning of which involves severe and uncontrollable gastrointestinal bleeding. Currently, there is no known potential cure to reverse the type of blood loss caused by Xarelto, other than possibly emergency dialysis. Individuals with severe pulmonary arterial hypertension are at greater risk for experiencing a Xarelto related bleed. While a warfarin overdose can be treated with Vitamin K and other substances, doctors can only wait for Xarelto to be flushed out from the patient’s body when extensive blood loss begins. Not even dialysis may be sufficient, and even a simple gastrointestinal bleed can become a fatal hemorrhage. Other potential injuries caused by Xarelto include:
- INFECTION ASSOCIATED WITH HIP OR KNEE REPLACEMENT SURGERY
- DECREASED HEMOGLOBIN (SUBSTANCE THAT CARRIES OXYGEN IN RED BLOOD CELLS)
- HEMATOMA (MASS IN THE BLOOD)
- PERIPHERAL EDEMA (SWELLING OF THE LOWER LIMBS)
- DYSPNEA (DIFFICULTY BREATHING)
LATEST IN XARELTO LITIGATION
In June 2016, the Institute of Safe Medication Practices reported that Xarelto was linked to more serious injuries than any other drug monitored. It accounted for more than 10,000 fatal, disabling and serious injuries. Thousands of claims have been filed against Janssen Pharmaceutical and Bayer Healthcare by people who have suffered severe bleeding as a result of taking the anticoagulant medication. Attorneys argue that is doctors and patients had known the risks, the patient would have perscribed warfarin, a different anticoagulant, where internal bleeding can be treated with high dosages of Vitamin K. As of February 2017, there were more than 15,000 Xarelto lawsuits consolidated before U.S. District Judge Eldon Fallon in the Eastern District of Louisiana, and another 1,000 consolidated in the state courts of Philadelphia.
DO YOU HAVE QUESTIONS ABOUT INJURIES RELATED TO XARELTO?
If you or a loved one have been affected by the drug Xarelto, we encourage you to consult with our team as soon as possible. With our extensive knowledge and expertise, you can rest assured that should you choose to work with us, you will have legal representation that you can trust. All initial consultations are free, and we don’t charge any up-front fees for representation. We handle all fees on a contingency basis, meaning that unless we’re successful, you don’t have to pay us. Please contact us at (405)510.0077 for a free consultation or request a case review here.